Diabetes Changes the Levels of Ionotropic Glutamate Receptors in the Rat Retina
Overview
Molecular Biology
Ophthalmology
Authors
Affiliations
Purpose: Diabetic retinopathy (DR) is a leading cause of vision loss and blindness among adults between the age 20 to 74. Changes in ionotropic glutamate receptor subunit composition can affect retinal glutamatergic neurotransmission and, therefore, contribute to visual impairment. The purpose of this study was to investigate whether diabetes leads to changes in ionotropic glutamate receptor subunit expression at the protein and mRNA level in the rat retina.
Methods: Changes in the expression of ionotropic glutamate receptor subunits were investigated at the mRNA and protein levels in retinas of streptozotocin (STZ)-induced diabetic and age-matched control rats. Animals were euthanized one, four and 12 weeks after the onset of diabetes. Retinal protein extracts were prepared, and the receptor subunit levels were assessed by western blotting. Transcript levels were assessed by real-time quantitative PCR.
Results: Transcript levels of most ionotropic glutamate receptor subunits were not significantly changed in the retinas of diabetic rats, as compared to age-matched controls but protein levels of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA), kainate, and N-methyl-D-aspartic acid receptors (NMDA) receptors were found to be altered.
Conclusions: The results provide evidence that diabetes affects the retinal content of ionotropic glutamate receptor subunits at the protein level. The possible implications of these changes on retinal physiology and visual impairment in DR are discussed.
Dionysopoulou S, Wikstrom P, Walum E, Georgakis S, Thermos K Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543179 PMC: 10974250. DOI: 10.3390/ph17030393.
Ancel P, Martin J, Doukbi E, Houssays M, Gascon P, Righini M Int J Mol Sci. 2023; 24(15).
PMID: 37569425 PMC: 10418671. DOI: 10.3390/ijms241512053.
Alipour N, Fallahnezhad S, Bagheri J, Babaloo H, Tahmasebi F, Sazegar G Iran J Basic Med Sci. 2023; 26(7):805-811.
PMID: 37396950 PMC: 10311974. DOI: 10.22038/IJBMS.2023.69668.15171.
Visual Dysfunction in Diabetes.
Eggers E Annu Rev Vis Sci. 2023; 9:91-109.
PMID: 37164027 PMC: 11262130. DOI: 10.1146/annurev-vision-111022-123810.
Contrast Increment and Decrement Processing in Individuals With and Without Diabetes.
Tang V, Symons R, Fourlanos S, Guest D, McKendrick A Invest Ophthalmol Vis Sci. 2023; 64(4):26.
PMID: 37083950 PMC: 10132322. DOI: 10.1167/iovs.64.4.26.